Nano-X Imaging Ltd. (NASDAQ:NNOX – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the six brokerages that are currently covering the company, Marketbeat.com reports. Two investment analysts have rated the stock with a sell rating, one has assigned a buy rating and three have assigned a strong buy rating to the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $5.00.
NNOX has been the subject of a number of research analyst reports. Cantor Fitzgerald raised shares of Nano-X Imaging to a “strong-buy” rating in a research note on Wednesday, March 4th. Zacks Research downgraded shares of Nano-X Imaging from a “hold” rating to a “strong sell” rating in a research note on Wednesday, April 22nd. D. Boral Capital reaffirmed a “buy” rating and issued a $5.00 target price on shares of Nano-X Imaging in a research note on Monday, April 20th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Nano-X Imaging in a research note on Friday, April 10th.
Check Out Our Latest Stock Report on NNOX
Hedge Funds Weigh In On Nano-X Imaging
Nano-X Imaging Stock Up 2.9%
NASDAQ:NNOX opened at $1.76 on Friday. Nano-X Imaging has a 12 month low of $1.59 and a 12 month high of $5.69. The firm has a market cap of $122.48 million, a PE ratio of -1.11 and a beta of 1.21. The company’s 50-day moving average price is $1.98 and its two-hundred day moving average price is $2.57.
Nano-X Imaging (NASDAQ:NNOX – Get Free Report) last announced its earnings results on Monday, April 20th. The company reported ($0.50) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.15) by ($0.35). Nano-X Imaging had a negative return on equity of 64.65% and a negative net margin of 790.87%.The company had revenue of $3.72 million during the quarter, compared to the consensus estimate of $3.99 million. During the same period in the prior year, the firm posted ($0.21) earnings per share. On average, research analysts expect that Nano-X Imaging will post -0.65 EPS for the current fiscal year.
About Nano-X Imaging
Nano-X Imaging Ltd. is a medical technology company developing and commercializing a digital X-ray imaging platform designed to lower the cost and increase the accessibility of diagnostic imaging. Its flagship product, the Nanox.ARC, leverages a proprietary micro-electromechanical system (MEMS) based digital X-ray source and advanced image processing software to provide 2D and 3D imaging capabilities on a compact footprint. The system aims to streamline radiology workflows and facilitate point-of-care diagnostics in hospitals, clinics and outpatient settings.
The Nanox.ARC platform integrates a novel cold cathode X-ray source, which enables multiple emission points without the need for rotating anode tubes.
See Also
- Five stocks we like better than Nano-X Imaging
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Receive News & Ratings for Nano-X Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nano-X Imaging and related companies with MarketBeat.com's FREE daily email newsletter.
